When evaluating pinealon price structure for academic or institutional procurement, researchers must assess raw chemical purity, analytical verification, and manufacturing standards. This guide analyzes the core cost determinants of synthetic Glu-Asp-Arg (EDR) while outlining quality standards required for reproducible preclinical research.
When evaluating pinealon price structure for academic or institutional procurement, researchers must assess raw chemical purity, analytical verification, and manufacturing standards. This guide analyzes the core cost determinants of synthetic Glu-Asp-Arg (EDR) while outlining quality standards required for reproducible preclinical research.
The market pinealon price for research-grade material is directly determined by analytical validation standards, solid-phase peptide synthesis (SPPS) purity thresholds, endotoxin quantification, and batch-specific documentation. Premium offerings feature verified ≥98% purity by reverse-phase HPLC, mass spectrometry structural confirmation, and US-based ISO 17025 testing rather than unverified bulk raw powder.
For investigators procuring pinealon 10mg for *in vitro* or animal models, raw mass is only one variable in total operational cost. Unverified compounds risk experimental invalidation due to truncated peptide sequences, residual counter-ions (such as trifluoroacetate), or bacterial endotoxin contamination. Securing fully documented reference materials from a validated research peptide supplier ensures data integrity across multi-phase laboratory assays.
Pinealon is a synthetic short-chain peptide bioregulator comprised of a three-amino-acid sequence: L-glutamic acid, L-aspartic acid, and L-arginine (H-Glu-Asp-Arg-OH, or EDR). With a molecular weight of approximately 388.37 g/mol, its ultra-short sequence provides unique structural stability and favorable membrane permeability characteristics in cell culture and tissue preparations.
Because of its small molecular footprint, EDR can cross cellular and nuclear membranes without complex carrier delivery systems. Preclinical studies suggest that this tripeptide interacts directly with specific histone proteins and DNA promoter regions, modulating chromatin conformation. Researchers investigating epigenetics frequently utilize short-chain bioregulators to study targeted gene transcription without the immunogenic risks associated with larger protein constructs.
In neurobiology assays, pinealon has been extensively evaluated for its protective effects against reactive oxygen species (ROS) and excitotoxic stress. Preclinical rodent models of ischemic brain injury and hypoxia demonstrate that EDR administration modulates intracellular calcium homeostasis and mitigates apoptotic cascades in hippocampal and cortical neurons.
In vitro assays utilizing primary neuronal cultures exposed to hydrogen peroxide or glutamate toxicity indicate that EDR upregulates antioxidant enzyme expression, including superoxide dismutase (SOD) and glutathione peroxidase. These findings suggest that pinealon functions as a chromatin-level modulator that stabilizes neuronal bioenergetics under pathological oxidative conditions.
Beyond immediate neuroprotection, EDR is studied for its role in cellular senescence and aging trajectories. Research models evaluating diploid fibroblast cultures and aging neuronal populations demonstrate that short peptide bioregulators can re-establish altered protein synthesis patterns characteristic of senescent cell lines.
In vitro data indicate that pinealon interacts directly with the nucleosome structure, influencing the transcription rates of genes responsible for cell survival, repair, and proliferation. By altering the methylation state of specific gene promoters, EDR provides a compelling model for studying non-coding genomic interactions and age-related functional decline in tissue-specific cell lines.
Evaluating pinealon price requires examining the vendor's analytical transparency. High-performance liquid chromatography (RP-HPLC) measures chemical purity by separating the target EDR tripeptide from synthesis deletion sequences or residual solvents. A reliable certificate of analysis (COA) must confirm a purity profile of ≥98%.
Electrospray ionization mass spectrometry (ESI-MS) provides definitive identity verification by confirming the precise molecular mass of 388.37 Da. Furthermore, because bacterial endotoxins (lipopolysaccharides) can trigger non-specific inflammatory signaling in neuronal cultures, laboratory-grade pinealon must undergo Chromogenic LAL testing to verify endotoxin levels below 0.01 EU/mg. Review our guide on peptide purity testing to understand how comprehensive validation protects experimental outcomes.
The overall cost structure of research-grade tripeptides is dictated by several critical manufacturing and quality-assurance steps. While short tripeptides like EDR are less complex to synthesize than long-chain polypeptides, achieving extreme chemical purity free of TFA (trifluoroacetate) salts requires specialized counter-ion exchange processes.
Key cost variables include:
• Synthesis Scale & Purification: Preparative HPLC purification steps scale non-linearly with higher purity thresholds (e.g., 98% vs 90%).
• Analytical Testing: Independent, lot-specific testing via accredited ISO 17025 laboratories using HPLC, MS, and LAL assays.
• Lyophilization Quality: Advanced freeze-drying protocols to produce stable, moisture-free cake structures that resist degradation.
• US Quality Controls: Domestically managed synthesis, packaging, and cleanroom handling under cGMP-compliant standards to prevent batch-to-batch variability.
When designing neurobiology or longevity research protocols, investigators often compare pinealon with other synthetic short peptides. A comparative evaluation clarifies operational differences in sequence size, target mechanism, and pricing models across peptide classes.
While pinealon (Glu-Asp-Arg) acts primarily as a tripeptide chromatin modulator in neuronal systems, epithalon research protocols focus on tetrapeptide (Ala-Glu-Asp-Gly) interactions with telomerase activity and pineal gland regulation. In contrast, heptapeptide neuroactive compounds like semax research compounds and selank preclinical formulations modulate central neurotransmitter systems, neurotrophic factors (BDNF), and GABAergic signaling. Understanding these structural and mechanistic distinctions helps research teams select the appropriate reference compounds for multi-target comparative studies.
Pinealon is supplied as a sterile, lyophilized white powder to ensure long-term chemical stability. To preserve peptide integrity prior to reconstituted assays, lyophilisate should be stored at -20°C in a desiccated environment, shielded from light exposure.
For *in vitro* applications, reconstitution should be performed using sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle swirl agitation is recommended to bring the tripeptide into solution. Aliquoting reconstituted solutions into single-use microcentrifuge tubes minimizes freeze-thaw degradation cycles. Researchers calculating concentration metrics can utilize our peptide reconstitution calculator for precise concentration planning.
Principal investigators, academic institutions, and corporate R&D laboratories requiring bulk quantities of short-chain bioregulators can leverage volume procurement structures. Establishing an institutional supply line reduces unit costs while guaranteeing batch consistency across long-term research initiatives.
PX1 Research maintains streamlined sourcing channels for enterprise clients, offering lot reservation, custom analytical testing panels, and volume pricing tiers. Facilities interested in bulk acquisition of EDR tripeptide or related bioregulatory compounds can submit procurement requisitions through our wholesale lab portal.
What factors directly influence the pinealon price per vial?
Pinealon price is determined by the purity level (typically ≥98% by RP-HPLC), the rigors of mass spectrometry identity verification, endotoxin testing standards, and whether the compound was synthesized and packaged under cGMP-compliant US laboratory conditions.
What is the primary chemical structure of Pinealon?
Pinealon is a synthetic tripeptide bioregulator with the amino acid sequence L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg or EDR), with a molecular weight of 388.37 g/mol.
Is Pinealon intended for clinical or therapeutic use in humans?
No. Pinealon is strictly a research compound intended exclusively for laboratory, in vitro, and preclinical animal research. It is not approved for human consumption, medical treatment, diagnosis, or therapeutic applications.
What preclinical research models utilize Pinealon?
Pinealon is primarily investigated in cell culture and animal models focusing on neuronal oxidative stress, hypoxic brain injury, cellular aging/senescence, histone binding, and epigenetic gene expression.
How should lyophilized Pinealon be stored upon arrival?
Lyophilized Pinealon should be stored at -20°C in a dry environment away from light. Once reconstituted, solutions should be aliquoted and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles.
How can researchers verify the purity of a Pinealon lot?
Researchers should demand a lot-specific Certificate of Analysis (COA) containing Reverse-Phase HPLC chromatograms showing ≥98% purity, Mass Spectrometry confirming the 388.37 Da molecular weight, and LAL assay results for endotoxin levels.
What solvent is recommended for reconstituting Pinealon for cell culture assays?
Pinealon is readily soluble in sterile water for injection, Bacteriostatic Water, or standard laboratory buffers such as Phosphate-Buffered Saline (PBS, pH 7.4).
What is PX1 Research's shipping standard for lab orders?
PX1 Research provides same-day shipping for orders placed Monday through Friday before cut-off times, shipping directly from dispatch facilities located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.